Frontiers in Cancer Chemistry Research

Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches

Research Articles

THOR-707: Retooling a Classic Cancer Fighter to Revolutionize Immunotherapy

Discover how THOR-707, a novel not-alpha IL-2 therapy, combined with pembrolizumab is revolutionizing cancer immunotherapy for advanced solid tumors.

Caleb Perry
Oct 02, 2025

Popular Articles